Rodman & Renshaw Initiates Coverage On Mural Oncology with Buy Rating, Announces Price Target of $15
Mural Oncology plc Ordinary Shares +3.42% Pre
Mural Oncology plc Ordinary Shares MURA | 3.63 3.63 | +3.42% 0.00% Pre |
Rodman & Renshaw analyst Tony Butler initiates coverage on Mural Oncology (NASDAQ:
MURA) with a Buy rating and announces Price Target of $15.